CLASS II Drug recall · Reported 8 Oct 2014 · FDA Enforcement Report

Zoledronic Acid Injection 5 mg per 05 mg/mL) single-use recalled

Sagent Pharmaceuticals is recalling Zoledronic Acid Injection 5 mg per 05 mg/mL) single-use, distributed nationwide in the US. The recall was initiated on 4 Mar 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesNDC 25021-830-82; Lot Numbers and Expiration Dates: Lot 30076, Expires 01/2015; Lot 30077, Expires 01/2015.
NDC25021-830
Quantity recalled10,622 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1615-2014
FDA event ID
67689
Recalling firm
Sagent Pharmaceuticals, Schaumburg, IL
Manufacturer
Sagent Pharmaceuticals
Classification
Class II
Status
Terminated
Recall initiated
4 Mar 2014
FDA classified
29 Sep 2014
Reported
8 Oct 2014
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Sterility

Timeline

4 Mar 2014Recall initiated by company
29 Sep 2014Classified by FDA+209 days
8 Oct 2014Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility; leaking of premix bags

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Zoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag packaged in a foil overwrap, Rx only, Sterile, For Intravenous Infusion, Mfd. for Sagent Pharmaceuticals Schaumburg, IL ---- NDC 25021-830-82

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Zoledronic Acid Injection 5 mg per 05 mg/mL) single-use recalled?

Yes. Sagent Pharmaceuticals recalled Zoledronic Acid Injection 5 mg per 05 mg/mL) single-use on 4 Mar 2014. The recall is Class II and its status is Terminated. Recall number D-1615-2014.

Why was it recalled?

Lack of Assurance of Sterility; leaking of premix bags

Which lots are affected?

NDC 25021-830-82; Lot Numbers and Expiration Dates: Lot 30076, Expires 01/2015; Lot 30077, Expires 01/2015.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Sagent Pharmaceuticals

All 23

Other Zoledronic Acid recalls

All 6